Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03237728
Status:
COMPLETED
Last Update Posted:
2020-01-22
First Post:
2017-07-31
Brief Title:
Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
Sponsor:
Tianjin Chasesun Pharmaceutical Co LTD
Organization:
Tianjin Chasesun Pharmaceutical Co LTD
Study Overview
Official Title:
Randomized Double-blind Placebo-controlled Clinical Study to Assess Safety Tolerance Pharmacokinetics Pharmacodynamic of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase I study of multiple-dose Kukoamine B Mesilate in Sepsis Patients
Detailed Description:
To Assess Safety Tolerance Pharmacokinetics Pharmacodynamic of multiple-dose Kukoamine B Mesilate in Sepsis Patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None